The reduced ability of peripherally restricted CB1R blockade to improve dyslipidemia and hepatic steatosis in CHOP KO mice led us to measure the hepatic eCB 'tone' in these mice. The gene discussed is DDIT3; the disease is Hepatic steatosis.